These metabolites attenuated adipose tissue inflammation and suppressed pro-inflammatory cytokines and JNK pathway activation in macrophages, suggesting a potential preventative approach for NAFLD by targeting adipose tissue inflammation [71]. Here, MAPK8 is linked to metabolic dysfunction-associated steatotic liver disease.